共 50 条
- [1] SERUM ISOFORM [-2]PROPSA (P2PSA) AND ITS DERIVATIVES, NAMELY %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN MEN YOUNGER THAN 60 YEARS OF AGE FOR PREDICTION OF PROSTATE CANCER. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY (PROMETHEUS PROJECT) [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E790 - E790
- [2] Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project [J]. BJU INTERNATIONAL, 2013, 112 (03) : 313 - 321
- [4] Re: Clinical Performance of Serum Isoform -2proPSA (p2PSA) and its Derivatives, Namely %p2PSA and PHI (Prostate Health Index) in Men Younger than 60 Years of Age: Results from a Multicentric European Study Editorial Comment [J]. JOURNAL OF UROLOGY, 2014, 192 (02): : 421 - 421
- [9] Establishment of reference intervals for serum [-2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 6453 - 6460